Related Experiment Video
Updated: Oct 18, 2025
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
A New Perspective on Cancer Therapy: Changing the Treaded Path?
Juliet N E Baidoo1,2, Sumit Mukherjee1,2, Khosrow Kashfi3,4
1Department of Chemistry, The College of Staten Island, City University of New York, Staten Island, NY 10314, USA.
Abstract:
During the last decade, we have persistently addressed the question, "how can the innate immune system be used as a therapeutic tool to eliminate cancer?" A cancerous tumor harbors innate immune cells such as macrophages, which are held in the tumor-promoting M2 state by tumor-cell-released cytokines. We have discovered that these tumor-associated macrophages (TAM) are repolarized into the nitric oxide (NO)-generating tumoricidal M1 state by the dietary agent curcumin (CC), which also causes recruitment of activated natural killer (NK) cells and cytotoxic T (Tc) cells into the tumor, thereby eliminating cancer cells as well as cancer stem cells. Indications are that this process may be NO-dependent. Intriguingly, the maximum blood concentration of CC in mice never exceeds nanomolar levels. Thus, our results submit that even low, transient levels of curcumin in vivo are enough to cause repolarization of the TAM and recruitment NK cells as well as Tc cells to eliminate the tumor. We have observed this phenomenon in two cancer models, glioblastoma and cervical cancer. Therefore, this approach may yield a general strategy to fight cancer. Our mechanistic studies have so far implicated induction of STAT-1 in this M2→M1 switch, but further studies are needed to understand the involvement of other factors such as the lipid metabolites resolvins in the CC-evoked anticancer pathways.
Insights
Curcumin (CC) repolarizes tumor-associated macrophages (TAM) to an anti-cancer M1 state, recruiting natural killer (NK) and cytotoxic T (Tc) cells. This dietary agent effectively eliminates cancer cells and cancer stem cells, even at low concentrations.
Area of Science:
- Immunology
- Oncology
- Natural Products Chemistry
Background:
- Tumors harbor M2-polarized macrophages that promote cancer growth.
- The innate immune system offers potential as a cancer therapeutic tool.
Purpose of the Study:
- To investigate curcumin's (CC) ability to repolarize tumor-associated macrophages (TAM) and enhance anti-cancer immunity.
- To explore the potential of CC as a therapeutic strategy against cancer.
Main Methods:
- Repolarization of TAM from M2 to M1 state using curcumin (CC).
- Assessment of natural killer (NK) cell and cytotoxic T (Tc) cell recruitment.
- Evaluation of cancer cell and cancer stem cell elimination in glioblastoma and cervical cancer models.
Main Results:
- Curcumin (CC) effectively repolarizes TAM to the tumoricidal M1 state.
- CC induces recruitment of activated NK cells and Tc cells into the tumor.
- Cancer cells and cancer stem cells were eliminated in glioblastoma and cervical cancer models, potentially via a nitric oxide (NO)-dependent mechanism.
- Effective anti-cancer activity was observed even with low, transient CC concentrations in vivo.
Conclusions:
- Curcumin (CC) demonstrates potential as a therapeutic agent by modulating the innate immune system against cancer.
- The CC-induced M2→M1 TAM switch, involving STAT-1 induction, offers a generalizable strategy for cancer treatment.
- Further research is needed to elucidate the role of factors like resolvins in CC-mediated anti-cancer pathways.
More Related Videos
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy